Hyperosmolar hyperglycemic syndrome induced by diazoxide and furosemide in a 5-year-old girl
| Autor: | Ryugo Hiramoto, Yuki Naruse, Haruka Nakazawa, Masato Mori |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
business.industry
Hyperosmolar hyperglycemic syndrome Endocrinology Diabetes and Metabolism Urinary system Furosemide Case Report medicine.disease diazoxide congenital hyperinsulinemia Lethargy Endocrinology Polyuria Anesthesia Diabetes mellitus Pediatrics Perinatology and Child Health Diazoxide Hyperinsulinemia Medicine furosemide medicine.symptom business Adverse effect medicine.drug |
| Zdroj: | Clinical Pediatric Endocrinology |
| ISSN: | 1347-7358 0918-5739 |
| Popis: | Hyperglycemia and hyperosmolar hyperglycemic syndrome (HHS) are the rare adverse effects of diazoxide. Furosemide has been reported to worsen glucose tolerance and cause HHS. A 5-yr-old girl presented to the emergency department with complaints of tachycardia, polyuria, and lethargy for 1 wk prior to hospitalization. She was treated with two diuretics for aortic valve reflux disease and diazoxide for congenital hyperinsulinemia. She was diagnosed with HHS based on her serum glucose level of 529 mg/dL and serum osmotic pressure of 357 mOsm/kg. There were no findings suggestive of new-onset diabetes mellitus. She had fever on admission and, was diagnosed with a urinary tract infection. The blood diazoxide level at the time of hospitalization was 25 µg/dL. Diazoxide use, even in patients with low diazoxide levels, may cause hyperglycemia. Patients on diuretics and diazoxide must be carefully monitored, considering the risk of developing HHS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|